Clinical Trials Logo

Gastric Disease clinical trials

View clinical trials related to Gastric Disease.

Filter by:

NCT ID: NCT06273319 Not yet recruiting - Gastric Disease Clinical Trials

The Effect of Oxygen Application With Double Nasal Cannula on Respiratory Complications

Start date: March 15, 2024
Phase: N/A
Study type: Interventional

To compare desaturation and respiratory complications by applying oxygen therapy with double nasal cannula to patients who are planned to undergo gastrointestinal endoscopy.

NCT ID: NCT06212206 Not yet recruiting - Gastric Disease Clinical Trials

PillBotâ„¢ - Remotely Controlled Capsule Endoscopy

Start date: May 2024
Phase: N/A
Study type: Interventional

The PillBot System is an endoscopic capsule imaging system intended for visualization of the stomach. In contrast to currently used passive capsule endoscopy systems, and FDA cleared active magnetic system, the PillBot System uses active, motorized propulsion technology to facilitate the navigation and positioning of the capsule within the stomach anatomy for imaging of the gastric mucosa by an operator

NCT ID: NCT05801055 Not yet recruiting - Gastric Disease Clinical Trials

A Study to Evaluate Endoscopic Visibility of Stomach After a Combination Drink of N-acetylcysteine and Simethicone

Start date: April 1, 2023
Phase: Phase 3
Study type: Interventional

Endoscopy is the diagnostic modality for most gastroduodenal diseases. During endoscopy mucus and foam may actually interfere with the visibility of the stomach mucosa. So the mixture of mucolytic ( N-acetyl cysteine) and anti-foaming agents ( simethicone) agents may disperse the bubbles and mucus in the stomach and enhance gastric visibility. This unique combination drink given 20-30 minutes prior to endoscopy is absolutely safe. There are previous studies from India, which was retrospective study. So, we have planned to conduct this randomized controlled trial on this issue. Adult patients undergoing diagnostic endoscopy will be randomized and one group (100 patients) will be given the combination drink whereas another group 9100 patients) will undergo an endoscopy after overnight fasting only, as a placebo drink may actually hamper the endoscopic visibility. Our primary outcome, gastric visibility will be assessed using a standard visibility scoring system.

NCT ID: NCT05392452 Completed - Clinical trials for Diabetes Mellitus, Type 2

Fully Closed-Loop Insulin Delivery in Abdominal Surgery (CLAB)

CLAB
Start date: August 9, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to assess the efficacy, safety and usability of perioperative fully-automated closed-loop insulin delivery versus standard insulin therapy in patients with diabetes other than type 1 diabetes undergoing elective major abdominal surgery.

NCT ID: NCT05249933 Recruiting - Capsule Endoscopy Clinical Trials

Pronase Granules in Gastric Cleaning

Start date: February 24, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

Magnetically controlled capsule endoscopy (MCE) is now widely used all over the world. However, the standard gastric preparation method by dimethicone we used clinically still has mucus at the bottom of the stomach. In this study, we aimed to determine whether pronase granules is helpful to improve the cleanliness of gastric mucosa in MCE.

NCT ID: NCT04479423 Completed - Capsule Endoscopy Clinical Trials

The Usage of Soda-Water in Gastric Preparation for Magnetically Controlled Capsule Endoscopy

Start date: December 3, 2020
Phase: N/A
Study type: Interventional

Magnetically controlled capsule endoscopy (MCE) is a noninvasive technique (90.4% sensitivity, 94.7% specificity and 93.4% accuracy) without requiring sedation or air insufflation, which makes it welcomed by most of participants. However, due to the large size of the stomach, clear views are obtained with the stomach distended. Participants were asked to drink 1000ml water for gastric preparation in a short time according to the standard procesure. It is hard for some participants especially the old and can cause discomfort. If the capsule stays in the stomach for a long time (>4 hours), it will affect the completion rate of small intestine examination and be inconvient to both of the endoscopist and patient. It is a promising way to fill the stomach with carbonated drinks in some diagnosis and treatment methods. A study using carbonated drinks for gastric filling in the procedure of multi slice spiral computed tomography (MSCT) showed higher diagnostic rate for gastric cancer (85%VS80%). Rapid filling and absorption, greater comfort feeling and little pressure changes lead to higher acceptance of participants. So, researchers have a novel idea using soda water to take place of pure water in the gastric preparation. The combination of gas and liquid in gastric filling greatly reduces the amount of fluid that participants need to drink, which makes the shorter preparation time and less feeling of fullness. In a pilot study before, investigators found the usage of soda water obtained similar gastric distention score and shorter gastric transit time (GTT) than standard preparation method. This prospective, single blind, randomized controlleds trial aimed to prove the safety and efficiency of soda water in the process of gastric preparation and explore the impact on the follow-up small bowel examination.

NCT ID: NCT04111393 Completed - Clinical trials for Bariatric Surgery Candidate

Transoral Removal of Specimen During Laparoscopic Gastric Resection

Start date: January 1, 2019
Phase:
Study type: Observational

Investigators aimed to present the patients who underwent laparoscopic gastrectomy with transoral specimen extraction.

NCT ID: NCT03776916 Completed - Gastric Disease Clinical Trials

Application of Simethicone in Esophagogastroscopy

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

This is a randomized controlled trial to comparing the different simethicone administration strategies for esophagogastroscopy. Recent studies have indicated that the administration of simethicone before endoscopic examination could shorten the procedure time and improve the diagnostic rate of the gastric mucosal lesions. But the time interval between simethicone administration and the examination has not been fully determined. This study will test whether the time of taking simethicone before endoscopy could influence the performance of the procedure in a randomized controlled trial. The results may benefit the current clinical practice.

NCT ID: NCT03267355 Recruiting - Pancreatic Diseases Clinical Trials

Indications and Outcomes of Endoscopic Ultrasound in Tanta

Start date: January 2016
Phase: N/A
Study type: Interventional

The aim is to evaluate the initial experience for the indications and outcomes of EUS in Tanta university hospital.

NCT ID: NCT03198871 Completed - Pancreatic Diseases Clinical Trials

IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population

Start date: May 24, 2018
Phase: Phase 4
Study type: Interventional

Number of patients with unsatisfactory pain relief defined as average visual analog scale (VAS) more than 5 with or without requirement of IVPCA for pain relief during the first 48 hours postoperative period will be compared between the two groups and form the primary outcome for the study. Postoperative pain intensity will be measured by Visual Analog Scale (VAS) with 0- being no pain and 10-being maximum pain and the analgesic efficacy in both groups will also be evaluated by the amount of total narcotic consumption (measured with IV morphine equivalent doses of analgesics used to provide pain relief).